Molecular pathways involved in the synergistic interaction of the PKCβ inhibitor enzastaurin with the antifolate pemetrexed in non-small cell lung cancer cells

Conventional regimens have limited impact against non-small cell lung cancer (NSCLC). Current research is focusing on multiple pathways as potential targets, and this study investigated molecular mechanisms underlying the combination of the PKCβ inhibitor enzastaurin with the multitargeted antifolat...

Descripción completa

Detalles Bibliográficos
Autores principales: Tekle, C, Giovannetti, E, Sigmond, J, Graff, J R, Smid, K, Peters, G J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2528136/
https://www.ncbi.nlm.nih.gov/pubmed/18728666
http://dx.doi.org/10.1038/sj.bjc.6604566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2528136/
https://www.ncbi.nlm.nih.gov/pubmed/18728666
http://dx.doi.org/10.1038/sj.bjc.6604566

Ejemplares similares